• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.

作者信息

Ala-Hurula V, Myllylä V V, Arvela P, Kärki N T, Hokkanen E

出版信息

Eur J Clin Pharmacol. 1979 Nov;16(5):355-60. doi: 10.1007/BF00605636.

DOI:10.1007/BF00605636
PMID:520404
Abstract
摘要

相似文献

1
Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.连续三次给药及持续用药期间酒石酸麦角胺的全身可用性。
Eur J Clin Pharmacol. 1979 Nov;16(5):355-60. doi: 10.1007/BF00605636.
2
Systemic availability of ergotamine tartrate in continuous medication.连续用药时酒石酸麦角胺的全身可用性。
Ups J Med Sci Suppl. 1980;31:20-2.
3
Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral doses.单次及重复口服剂量后，健康受试者中酒石酸麦角胺的全身可用性。
Ups J Med Sci Suppl. 1980;31:7-9.
4
Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers.偏头痛患者静脉注射和肌肉注射麦角胺后的药代动力学。
Eur J Clin Pharmacol. 1982;23(3):235-40. doi: 10.1007/BF00547560.
5
Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.口服、直肠给药和肌肉注射后酒石酸麦角胺的全身可用性。
Eur J Clin Pharmacol. 1979 Feb 19;15(1):51-5. doi: 10.1007/BF00563557.
6
The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve.单剂量酒石酸麦角胺对偏头痛患者外周动脉的影响：方法学方面及时间效应曲线
Acta Pharmacol Toxicol (Copenh). 1980 Aug;47(2):151-6. doi: 10.1111/j.1600-0773.1980.tb01855.x.
7
Ergotamine-induced anorectal strictures: report of five cases.麦角胺所致肛门直肠狭窄：5例报告
Dis Colon Rectum. 2002 Feb;45(2):271-2. doi: 10.1007/s10350-004-6160-x.
8
Ketoprofen and ergotamine in acute migraine.
J Intern Med. 1992 May;231(5):551-4. doi: 10.1111/j.1365-2796.1992.tb00973.x.
9
[Use of ergotamine tartrate as a suppository in migraine].
Nord Med. 1968 Jul 18;80(29):942-4.
10
A new look at the use of ergotamine.麦角胺使用的新视角。
Drugs. 1976 Dec;12(6):449-53. doi: 10.2165/00003495-197612060-00004.

引用本文的文献

1
Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy.干预先兆期以预防偏头痛：药物治疗的前景。
CNS Drugs. 2024 Jul;38(7):533-546. doi: 10.1007/s40263-024-01091-2. Epub 2024 May 31.
2
Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine.发作期缺乏与脑实质的结合表明在硝酸甘油诱发的偏头痛期间，血脑屏障对11C-二氢麦角胺保持完整。
Brain. 2016 Jul;139(Pt 7):1994-2001. doi: 10.1093/brain/aww096. Epub 2016 May 27.
3
Permeability of ergot alkaloids across the blood-brain barrier in vitro and influence on the barrier integrity.

本文引用的文献

1
[About the fate of natural and dihydrogenated ergot alkaloids in the organism].[关于天然和二氢麦角生物碱在生物体内的命运]
Schweiz Med Wochenschr. 1947 Nov 1;77(44):1161-3.
2
Ergotamine tolerance in patients with migraine.
J Am Med Assoc. 1955 Mar 12;157(11):881-4. doi: 10.1001/jama.1955.02950280005002.
3
Ergotamine induced headaches in migrainous patients.麦角胺诱发偏头痛患者头痛。
Headache. 1973 Jul;13(2):65-7. doi: 10.1111/j.1526-4610.1973.hed1302065.x.
麦角生物碱透过血脑屏障的体外渗透性及其对屏障完整性的影响。
Mol Nutr Food Res. 2012 Mar;56(3):475-85. doi: 10.1002/mnfr.201100431. Epub 2011 Dec 7.
4
Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers.偏头痛患者静脉注射和肌肉注射麦角胺后的药代动力学。
Eur J Clin Pharmacol. 1982;23(3):235-40. doi: 10.1007/BF00547560.
5
Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine.偏头痛患者中麦角胺的药代动力学与临床疗效之间的相关性。
Eur J Clin Pharmacol. 1982;21(5):397-402. doi: 10.1007/BF00542326.
6
Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.偏头痛患者口服和直肠给药后酒石酸麦角胺的生物利用度较低。
Br J Clin Pharmacol. 1983 Dec;16(6):695-9. doi: 10.1111/j.1365-2125.1983.tb02243.x.
7
Rectal drug administration: clinical pharmacokinetic considerations.直肠给药：临床药代动力学考量
Clin Pharmacokinet. 1982 Jul-Aug;7(4):285-311. doi: 10.2165/00003088-198207040-00002.
8
Ergotamine abuse and extra-hepatic portal hypertension.麦角胺滥用与肝外门静脉高压症
Postgrad Med J. 1985 May;61(715):461-3. doi: 10.1136/pgmj.61.715.461.
9
Clinical pharmacokinetics of ergotamine in migraine and cluster headache.麦角胺在偏头痛和丛集性头痛中的临床药代动力学。
Clin Pharmacokinet. 1985 Jul-Aug;10(4):334-52. doi: 10.2165/00003088-198510040-00004.
10
Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.健康志愿者口服和直肠给药后麦角胺的药代动力学。
Eur J Clin Pharmacol. 1986;30(3):331-4. doi: 10.1007/BF00541538.
4
A new look at the use of ergotamine.麦角胺使用的新视角。
Drugs. 1976 Dec;12(6):449-53. doi: 10.2165/00003495-197612060-00004.
5
Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.离体犬脑动脉和外周动脉对麦角胺的反应性。
Naunyn Schmiedebergs Arch Pharmacol. 1976;292(2):113-8. doi: 10.1007/BF00498580.
6
Further studies concerning the toxicity of ingested ergot sclerotia (Claviceps purpurea) to young and growing pigs.
Res Vet Sci. 1977 Mar;22(2):146-50.
7
9-10-dihydroergotamine: production of antibodies and radioimmunoassay.9-10-二氢麦角胺：抗体的产生及放射免疫测定
Experientia. 1976 Feb 15;32(2):234-6. doi: 10.1007/BF01937784.
8
Toxic effects of ergotamine used for migraine.用于偏头痛治疗的麦角胺的毒性作用。
Headache. 1978 May;18(2):95-8. doi: 10.1111/j.1526-4610.1978.hed1802095.x.
9
Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.口服、直肠给药和肌肉注射后酒石酸麦角胺的全身可用性。
Eur J Clin Pharmacol. 1979 Feb 19;15(1):51-5. doi: 10.1007/BF00563557.
10
Migraine. I. Classification and pathogenesis.偏头痛。一、分类与发病机制。
JAMA. 1978 Jun 2;239(22):2380-3. doi: 10.1001/jama.239.22.2380.